Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Neisha Sundaram, Teck Chuan Voo & Clarence C. Tam. (2020) Adolescent HPV vaccination: empowerment, equity and ethics. Human Vaccines & Immunotherapeutics 16:8, pages 1835-1840.
Read now
Read now
Sandra D Isidean, Joseph E Tota, Julien A Gagnon & Eduardo L Franco. (2015) Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs. Expert Review of Vaccines 14:1, pages 119-133.
Read now
Read now
Xavier Bresse, Christoph Goergen, Bernhard Prager & Elmar Joura. (2014) Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost–effectiveness analysis. Expert Review of Pharmacoeconomics & Outcomes Research 14:2, pages 269-281.
Read now
Read now
Articles from other publishers (22)
Jeremy D. Goldhaber-Fiebert & Lauren E. Cipriano. (2023) Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis. Medical Decision Making 43:7-8, pages 914-929.
Crossref
Crossref
Phuong T. Tran, Munaza Riaz, Ziyan Chen, Cong Bang Truong & Vakaramoko Diaby. (2022) An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines. Clinical Drug Investigation 42:5, pages 377-390.
Crossref
Crossref
Joost J.M. Simons, Nora Vida, Tjalke A. Westra & Maarten J. Postma. (2020) Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands. Vaccine 38:30, pages 4687-4694.
Crossref
Crossref
Karen Canfell, Jane J. Kim, Shalini Kulasingam, Johannes Berkhof, Ruanne Barnabas, Johannes A. Bogaards, Nicole Campos, Chloe Jennett, Monisha Sharma, Kate T. Simms, Megan A. Smith, Louiza S. Velentzis, Marc Brisson & Mark Jit. (2019) HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Research 8, pages 100184.
Crossref
Crossref
Venetia Qendri, Johannes A. Bogaards & Johannes Berkhof. (2018) Pricing of HPV vaccines in European tender-based settings. The European Journal of Health Economics 20:2, pages 271-280.
Crossref
Crossref
Venetia Qendri, Johannes A Bogaards & Johannes Berkhof. (2018) Who Will Benefit From Expanding HPV Vaccination Programs to Boys?. JNCI Cancer Spectrum 2:4.
Crossref
Crossref
Mélanie Drolet, Élodie Bénard, Mark Jit, Raymond Hutubessy & Marc Brisson. (2018) Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value in Health 21:10, pages 1250-1258.
Crossref
Crossref
Ho-Lan Peng, Samantha Tam, Li Xu, Kristina R. Dahlstrom, Chi-Fang Wu, Shuangshuang Fu, Chengxue Zhong, Wenyaw Chan, Erich M. Sturgis, Lois Ramondetta, Libin Rong, David R. Lairson & Hongyu Miao. (2018) Age-Structured Population Modeling of HPV-related Cervical Cancer in Texas and US. Scientific Reports 8:1.
Crossref
Crossref
Gilla K. Shapiro, Juliet Guichon, Gillian Prue, Samara Perez & Zeev Rosberger. (2017) A Multiple Streams analysis of the decisions to fund gender-neutral HPV vaccination in Canada. Preventive Medicine 100, pages 123-131.
Crossref
Crossref
Giampiero Favato, Tania Easton, Riccardo Vecchiato & Emmanouil Noikokyris. (2017) Ecological validity of cost-effectiveness models of universal HPV vaccination: A systematic literature review. Vaccine 35:20, pages 2622-2632.
Crossref
Crossref
David R Lairson, Shuangshuang Fu, Wenyaw Chan, Li Xu, Zeena Shelal & Lois Ramondetta. (2017) Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas. Gynecologic Oncology 145:1, pages 108-113.
Crossref
Crossref
Joshua Pink, Ben Parker & Stavros Petrou. (2016) Cost Effectiveness of HPV Vaccination: A Systematic Review of Modelling Approaches. PharmacoEconomics 34:9, pages 847-861.
Crossref
Crossref
Mckenna Longacre, Nicole Snyder, Genevieve Housman, Meghan Leary, Karolina Lapinska, Sarah Heerboth, Amber Willbanks & Sibaji Sarkar. (2016) A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis. International Journal of Molecular Sciences 17:5, pages 759.
Crossref
Crossref
Dania Bucchi, Fabrizio Stracci, Nicola Buonora & Giuseppe Masanotti. (2016) Human papillomavirus and gastrointestinal cancer: A review. World Journal of Gastroenterology 22:33, pages 7415.
Crossref
Crossref
Riccardo A. Audisio, Giancarlo Icardi, Andrea M. Isidori, Carlo A. Liverani, Alberto Lombardi, Luciano Mariani, Francesco Saverio Mennini, David A. Mitchell, Andrea Peracino, Sergio Pecorelli, Giovanni Rezza, Carlo Signorelli, Giovanni Vitali Rosati & Gian Vincenzo Zuccotti. (2016) Public health value of universal HPV vaccination. Critical Reviews in Oncology/Hematology 97, pages 157-167.
Crossref
Crossref
Paolo Bonanni, Giovanni Gabutti, Nadia Demarteau, Sara Boccalini & Giuseppe La Torre. (2015) Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: where is the greatest benefit for cervical cancer prevention in Italy?. BMC Infectious Diseases 15:1.
Crossref
Crossref
Katrin Haeussler, Andrea Marcellusi, Francesco Saverio Mennini, Giampiero Favato, Mauro Picardo, Giorgia Garganese, Marco Bononi, Silvano Costa, Giovanni Scambia, Peter Zweifel, Alessandro Capone & Gianluca Baio. (2015) Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study. Value in Health 18:8, pages 956-968.
Crossref
Crossref
Mohamed-Béchir Ben Hadj Yahia, Anaïs Jouin-Bortolotti & Benoît Dervaux. (2015) Extending the Human Papillomavirus Vaccination Programme to Include Males in High-Income Countries: A Systematic Review of the Cost-Effectiveness Studies. Clinical Drug Investigation 35:8, pages 471-485.
Crossref
Crossref
Horng-Jyh Tsai. (2015) Clinical cancer chemoprevention: From the hepatitis B virus (HBV) vaccine to the human papillomavirus (HPV) vaccine. Taiwanese Journal of Obstetrics and Gynecology 54:2, pages 112-115.
Crossref
Crossref
L. Ribassin-Majed, C. Hill & R. Lounes. (2015) Efficacy of vaccination against HPV infection to prevent cervical cancer in France. Public Health 129:1, pages 78-81.
Crossref
Crossref
Kevin Marsh, Ruth Chapman, Rebecca F. Baggaley, Nathalie Largeron & Xavier Bresse. (2014) Mind the gaps: What's missing from current economic evaluations of universal HPV vaccination?. Vaccine 32:30, pages 3732-3739.
Crossref
Crossref
Susanna Esposito, Paolo Durando, Samantha Bosis, Filippo Ansaldi, Claudia Tagliabue & Giancarlo Icardi. (2014) Vaccine-preventable diseases: From paediatric to adult targets. European Journal of Internal Medicine 25:3, pages 203-212.
Crossref
Crossref